K-RAS MUTATIONS IN HUMAN ADENOCARCINOMA OF THE LUNG - ASSOCIATION WITH SMOKING AND OCCUPATIONAL EXPOSURE TO ASBESTOS

被引:125
作者
HUSGAFVELPURSIAINEN, K
HACKMAN, P
RIDANPAA, M
ANTTILA, S
KARJALAINEN, A
PARTANEN, T
TAIKINAAHO, O
HEIKKILA, L
VAINIO, H
机构
[1] UNIV HELSINKI, CENT HOSP, DEPT THORAC & CARDIOVASC SURG, SF-00100 HELSINKI 10, FINLAND
[2] INT AGCY RES CANC, F-69372 LYON, FRANCE
[3] UNIV OULU, INST ELECTRON OPT, SF-90100 OULU 10, FINLAND
关键词
D O I
10.1002/ijc.2910530213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated point mutational activation of the ras genes (K-ras codons 12, 13 and 61; N-ras codons 12, 13 and 61; H-ras codons 12 and 61) in primary, resected lung cancer by dot blotting and oligonucleotide hybridization. K-ras mutations were found in 14 (29%) of the 48 lung tumour specimens examined, but no N-ras or H-ras mutations were found. The highest frequency of K-ras mutation was observed in adenocarcinoma: 12 of the 21 samples studied (57%) had a mutation, which is one of the highest frequencies reported for lung adenocarcinoma. The commonest type of mutation in these lung tumour samples consisted of transversions: we observed 11, of which 8 (57% of all mutations) were G to T transversions. Most of the 48 patients studied had a history of heavy smoking, either with or without evidence of occupational exposure to asbestos. Statistical analysis revealed-in addition to the highly significant association between the adenocarcinoma type of lung cancer and K-ras mutation-a clear association of K-ras mutations with heavy life-time smoking (greater-than-or-equal-to 50 pack-years of cigarette smoking; odds ratio (OR) 4.9, 90% CI 1.2 - 19.5, multivariate analysis). In addition, occupational asbestos exposure showed an elevated, but non-significant, OR of 2.2 (90% CI 0.6 - 8.7) with the presence of K-ras mutation. We conclude that the occurrence of K-ras mutations in adenocarcinoma of the lung is frequent, and that such mutations are associated with heavy life-time exposure to tobacco smoke, possibly in combination with occupational exposure to asbestos fibres.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 33 条
[1]  
ALEXANDROV K, 1992, IN PRESS CANCER RES
[2]  
ANTMAN K, 1987, ASBESTOS RELATED MAL, P412
[3]   RAS ONCOGENES - THEIR ROLE IN NEOPLASIA [J].
BARBACID, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) :225-235
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   SERUM ONCOPROTEINS AND GROWTH-FACTORS IN ASBESTOSIS AND SILICOSIS PATIENTS [J].
BRANDTRAUF, PW ;
SMITH, S ;
HEMMINKI, K ;
KOSKINEN, H ;
VAINIO, H ;
NIMAN, H ;
FORD, J .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (06) :881-885
[6]  
COTE RJ, 1991, CANCER RES, V51, P5410
[7]  
DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1
[8]  
DEVRIES MV, 1986, GENE, V50, P313
[9]   ROLE OF PEPTIDE GROWTH-FACTORS IN ASBESTOS-RELATED HUMAN LUNG-CANCER [J].
GUILLEMIN, B ;
ZHANG, YH ;
LEE, TC ;
ROM, WN .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 643 :245-257
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53